We are international
• about myeloma TEXT SIZE   
Ask Dr Durie



Have a question? Submit it to AskDrDurie@myeloma.org!


IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org.

Our archives are brimming with useful information directed at - and asked by - patients, caregivers, and other interested parties... so please watch the episodes below, and share them as much as possible so that others may benefit!




#Ask Dr. Durie
    next      view all

04.28.16   How long does it take to assess if a particular treatment is working?

In this week’s video, Dr. Brian Durie provides insight on how to assess response to various myeloma treatments.


By checking M-protein levels after each cycle of treatment, we can assess the true benefits of each therapy.

04.21.16   How common are low platelet counts after autologous stem cell transplant?

In this week’s video, Dr. Brian Durie explains that patients should keep a close eye on their platelet counts after undergoing a stem cell transplant.


If platelet counts drop too low, therapy adjustments should be considered.

04.14.16   Does immune therapy work for high-risk myeloma?

In this week’s video, Dr. Brian Durie discusses how immune therapies work in the treatment of myeloma.


Best bets to fight high-risk myeloma are therapies that replace, rather than manipulate, the immune system. 

04.07.16   Do all myeloma patients become high-risk at some point?

In this week’s video, Dr. Brian Durie answers questions about high-risk multiple myeloma.


Over time, different myeloma patterns emerge. 

03.31.16   What is the status of the measles vaccine trial?

In this week’s video, Dr. Brian Durie discusses the use of virus trials in the treatment of multiple myeloma.


The virus trials are generating excitement. Contact the IMF to learn more.

03.24.16   If no treatment for multiple myeloma is recommended, is a bone marrow biopsy necessary?

In this week’s video, Dr. Durie answers a question about whether a patient should undergo a bone marrow biopsy, even if treatment is not recommended at the time.

Bottom Line: 

If you are unsure about diagnosis, treatment, or testing, consult an expert.

03.17.16   After relapse, I’m responding well to Rev/dex. Should I continue this treatment?

In this week's video, Dr. Brian Durie addresses if patients should continue certain treatments.

Bottom Line: 

When the disease is controlled, ongoing maintenance is still a good choice. 

03.10.16   Is it possible to have symptoms of myeloma in your head?

In this week's video, Dr. Brian Durie discusses how fear may lead to imagined symptoms of myeloma. 

Bottom Line:

Successful treatment will drive away symptoms that exist only in your mind.

03.03.16   What are the new drug trials available for patients in 2016?

In this week's video, Dr. Brian Durie talks about which new drug trials are available for patients in 2016.

Bottom Line:

Check clinicaltrials.gov or contact the IMF InfoLine @ 800-452-CURE for more info.

02.25.16   How does one achieve a strong communicative relationship with one’s doctor?

In this week's video, Dr. Brian Durie discusses how to develop a strong communicative relationship with your doctor.

Bottom line:

Make sure you find a doctor with a communication style that suits your needs. 

    next      view all